Patient symptoms likely arise from mutations disturbing the role that the encoded NMDA receptor subunit, GluN2B, plays at neuronal connections in the developing nervous system.
Since mutations can affect NMDA receptor localization, data on whether AMPA/NMDA ratios changed would be informative. It follows from the methodology that AMPA currents were recorded on a regular basis.